Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche Diagnostics equipment utilised in genome research

Roche Diagnostics equipment utilised in genome research

6th August 2010

Roche Diagnostics has provided technology and expertise to the Baylor College of Medicine Human Genome Sequencing Center in order to further research into the human genome and related diseases.

The US-based facility has worked with the science company’s NimbleGen division to standardise its target enrichment human disease research studies on Roche sequence capture exome technology.

Over the next two years, Baylor will use the NimbleGen SeqCap EZ Exome to sequence more than 5,000 exomes, in order to better understand the relationship genetic mutations can have on diseases such as cancer, heart disease and diabetes.

The centre has been working with Roche for more than three years and praised the manufacturer for the “superb performance” of its technology.

Dr Andreas Gortz, vice-president of marketing at Roche NimbleGen, said: “We believe studies like these … will provide insights on the missing heritability of many genetic diseases, hopefully leading to future breakthroughs in diagnostic and therapeutic tools.”

Last month, Roche Diagnostics attended the American Association for Clinical Chemistry clinical lab expo to demonstrate a range of new technologies, including the cobas 8000 analyser series and the ACCU-CHEK Inform II unit.ADNFCR-8000103-ID-800015541-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.